(25)
24 Junio 2014 - 9:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number
001-33560
|
Issuer:
|
CAPSTONE THERAPEUTICS CORP.
|
|
Exchange:
|
NASDAQ GLOBAL MARKET
|
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
|
|
|
|
|
Address:
|
1275 West Washington Street, Suite 104
|
|
|
Tempe, Arizona 85281
|
|
Telephone Number:
|
(602) 286-5520
|
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
(Description of class of securities)
Rights to Purchase 1/100 of a Share of Series A Preferred Stock
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from
listing and registration:
o
17 CFR 240.12d2-2(a)(1)
o
17 CFR 240.12d2-2(a)(2)
o
17 CFR 240.12d2-2(a)(3)
o
17 CFR 240.12d2-2(a)(4)
o
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
1
x
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
June 24, 2014
|
|
/s/ John M. Holliman, III
|
|
Executive Chairman
|
|
Date
|
|
Name
|
|
Title
|
|
1
Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Capstone Therapeutics (QB) (USOTC:CAPS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Capstone Therapeutics (QB) (USOTC:CAPS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024